Download DNB 2019 Dec 2019 Dec NUCLEAR MEDICINE PAPER III Question Paper

FirstRanker.com

FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
DECEMBER 2019

--- Content provided by​ FirstRanker.com ---

Time: 3 Hours NM/D/19/24/111 Max. Marks: 100

Important Instructions:

• Attempt all questions in order.

--- Content provided by‍ FirstRanker.com ---

• Each question carries 10 marks.
• Read the question carefully and answer to the point neatly and legibly.
• Do not leave any blank pages between two answers.
• Indicate the question number correctly for the answer in the margin space.
• Answer all the parts of a single question together.

--- Content provided by⁠ FirstRanker.com ---

• Start the answer to a question on a fresh page or leave adequate space between two answers.
• Draw table/diagrams/flowcharts, wherever appropriate.

Write short notes on:

1. Define biochemical recurrence in prostate cancer. Explain the treatment protocol for PSMA-ligand based radionuclide therapy. 2+8
2. Define hyperparathyroidism and its types. Discuss the role of nuclear medicine in management of parathyroid adenoma. 3+7

--- Content provided by FirstRanker.com ---

3. a) FFR and CFR. 5+5
   b) Cardiac PET protocol for imaging cardiac sarcoidosis.
4. What is refractory thyroid cancer? Discuss the treatment options for a patient with refractory thyroid cancer. 10
5. a) Sentinel node imaging — procedure and uses. 5+5
   b) Radiological anatomy of liver segments and its significance. Also illustrate with diagrams.

--- Content provided by⁠ FirstRanker.com ---

6. How will you modify the PET-CECT protocol in evaluation of neuroendocrine tumors and liver metastases, with respect to oral contrast agent and the protocol for contrast enhanced CT? 10
7. a) Hypoxia imaging. 5+5
   b) Tau protein imaging in dementia.
8. a) PET-CT in evaluation of lung cancer. 5+5
   b) Nuclear Medicine in evaluation of obstructive uropathy.

--- Content provided by⁠ FirstRanker.com ---

9. a) Imaging in GI bleed. 5+5
   b) 18F-NaF imaging — advantages and disadvantages.
10. a) Radioimmunotherapy. 5+5
    b) Perchlorate discharge test.

POSSESSION/USE OF CELL PHONES IS NOT PERMITTED INSIDE THE EXAMINATION HALL.

--- Content provided by‌ FirstRanker.com ---